切换至 "中华医学电子期刊资源库"

中华针灸电子杂志 ›› 2025, Vol. 14 ›› Issue (02) : 50 -53. doi: 10.3877/cma.j.issn.2095-3240.2025.02.002

论著

董氏奇穴治疗肝郁痰凝型乳癖病的疗效观察
昌恩惠1, 李兰兰1, 刘红霞1, 储浩然2,, 陈芳芳3   
  1. 1. 244000 铜陵市中医医院妇科
    2. 230061 合肥,安徽中医药大学第二附属医院名医堂
    3. 244000 铜陵市中医医院功能检查科
  • 收稿日期:2023-07-24 出版日期:2025-05-15
  • 通信作者: 储浩然
  • 基金资助:
    安徽省“十四五”省级中医优势特色专科建设项目(皖中医药服务秘〔2021〕71 号)

Clinical observation of the effect of Dong′s Extraordinary Acupoints in treating liver stagnation and phlegm-condensation type mammary hyperplasia

Enhui Chang1, Lanlan Li1, Hongxia Liu1, Haoran Chu2,, Fangfang Chen3   

  1. 1. Department of Gynecology,Tongling Hospital of Traditional Chinese Medicine,Tongling 244000,China
    2. Famous Doctors Hall,The Second Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230061,China
    3. Department of Functional Examination,Tongling Hospital of Traditional Chinese Medicine,Tongling 244000,China
  • Received:2023-07-24 Published:2025-05-15
  • Corresponding author: Haoran Chu
引用本文:

昌恩惠, 李兰兰, 刘红霞, 储浩然, 陈芳芳. 董氏奇穴治疗肝郁痰凝型乳癖病的疗效观察[J/OL]. 中华针灸电子杂志, 2025, 14(02): 50-53.

Enhui Chang, Lanlan Li, Hongxia Liu, Haoran Chu, Fangfang Chen. Clinical observation of the effect of Dong′s Extraordinary Acupoints in treating liver stagnation and phlegm-condensation type mammary hyperplasia[J/OL]. Chinese Journal of Acupuncture and Moxibustion(Electronic Edition), 2025, 14(02): 50-53.

目的

观察董氏奇穴治疗肝郁痰凝型乳癖病的临床疗效。

方法

选取2021年2月至2023年2月铜陵市中医医院妇科门诊收治的肝郁痰凝型乳癖病患者60 例,按照随机数字表法将患者分为治疗组和对照组,每组30 例。 治疗组选用双侧外三重穴(董氏奇穴)及双侧足三里、丰隆、三阴交、合谷、太冲予以针刺治疗,月经结束后第1 天开始针刺,1 次/d,月经期间停止针刺;对照组采用中成药红金消结胶囊口服治疗,月经结束后第1 天开始服用,4 粒/次,3 次/d,月经期间停药。 2 组均治疗3 个月。 观察2 组患者治疗前后乳房疼痛积分、乳房肿块直径的变化,并评定2 组临床疗效及安全性。

结果

对照组总有效率73.3%(22/30),治疗组总有效率93.3%(28/30),2 组患者疗效比较,差异具有统计学意义(χ2 =4.320,P<0.05)。 治疗后,2 组患者乳房疼痛积分、乳房肿块直径均较治疗前降低(t=9.175、7.413、6.637、3.452,P<0.05),2 组患者乳房疼痛积分、乳房肿块直径比较,差异均无统计学意义(t=-1.470、-1.924,P>0.05)。

结论

董氏奇穴针刺法和红金消结胶囊均可减轻乳房疼痛、缩小乳房肿块,提高治疗后总有效率,两种治疗方法疗效相当。

Objective

This study aimed to evaluate the clinical efficacy of Dong′s Extraordinary Acupoints in treating mammary hyperplasia caused by liver stagnation and phlegm congealing.

Methods

A total of 60 patients diagnosed with this condition at the Gynecology Outpatient Department of Tongling Hospital of Traditional Chinese Medicine from February 2021 to February 2023 were randomly assigned into a treatment group (n=30) and a control group (n =30). The treatment group underwent acupuncture at bilateral Outer Sanjiao (Dong′s Extraordinary Acupoints),Zusanli (ST 36),Fenglong (ST 40),Sanyinjiao (SP 6),Hegu(LI 4),and Taichong (LR 3). Acupuncture was performed once daily from the first day after menstruation until the next menstrual cycle,with treatment paused during menstruation. The control group received oral Hongjin Xiaojie Capsules (4 capsules per dose,three times daily,excluding menstrual periods). Both groups were treated for three months. Changes in breast pain scores and breast mass diameters before and after treatment were assessed. The clinical efficacy and safety of the interventions were also evaluated.

Results

The total effective rate in the treatment group was 93.3% (28/30),significantly higher than 73.3% (22/30) in the control group (χ2 =4.320, P<0.05). After treatment,both groups showed significant reductions in breast pain scores and breast mass diameters compared to baseline(t=9.175,7.413,6.637,3.452, P<0.05). However,no statistically significant differences were found between the two groups after treatment (t =-1.470,-1.924, P>0.05).

Conclusion

Both Dong′s Extraordinary Acupoint Acupuncture Method and Hongjin Xiaojie Capsules effectively relieve breast pain,reduce breast lumps,and improve treatment outcomes. The therapeutic efficacy of these two approaches is comparable,offering viable treatment options for mammary hyperplasia due to liver stagnation and phlegm congealing.

表1 2 组肝郁痰凝型乳癖病患者治疗前后乳房疼痛积分比较(分,±s
表2 2 组肝郁痰凝型乳癖病患者治疗前后乳房肿块直径比较(mm,±s
1
Zeinomar N,Phillips KA,Daly MB,et al. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: findings from a prospective family study cohort [ J].International Journal of Cancer,2019,145(2):370-379.
2
郭莉.乳腺增生病诊断与疗效标准的评价[C].第十届全国中医暨中西医结合乳腺病学术会议,2007.
3
马薇,金泉秀,吴云飞,等.乳腺增生症诊治专家共识[J].中国实用外科杂志,2016,36(7):759-762.
4
世界中医药学会联合会乳腺病专业委员会,刘胜,王怡,等.中西医结合临床诊疗乳腺增生专家共识[J].中华中医药杂志,2023,38(3):1159-1164.
5
陈红风.中医外科学[M].北京:中国中医药出版社,2016.
6
马薇,金泉秀,吴云飞,等.乳腺增生症诊治专家共识[J].中国实用外科杂志,2016,36(7):759-762.
7
邱雅昌.董氏奇穴实用手册[M].北京:人民卫生出版社,2012.
8
张雷,林艳,张锐.红金消结胶囊治疗乳腺增生症160 例疗效观察[J].中国药房,2010,21(47):4497-4498.
9
来保勇,贾丽燕,刘宇飞.红金消结胶囊治疗乳腺增生症随机对照试验的系统评价与试验序贯分析[J].中国中药杂志,2020,45(19):4776-4783.
10
《中成药治疗优势病种临床应用指南》标准化项目组.中成药治疗乳腺增生症临床应用指南(2021年)[J].中国中西医结合杂志,2022,42(5):517-524.
11
陈明阳,姜大庆.红金消结胶囊在乳腺增生疾病的运用[J].中医药临床杂志,2017,29(7):1126-1128.
No related articles found!
阅读次数
全文


摘要